Inspire Veterinary Partners, Inc. Class A (IVP) AI Stock Analysis

• Market Cap: $3.53M
• Dividend Yield: N/A
• Average Volume (3M): 40.48K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.82
• Revenue Growth: -0.50%
• EPS Growth: 94.60%
• Country: US
• Employees: 113
• Sector: Consumer Cyclical
• Sector Strength: 57
• Industry: Personal Products & Services
• EPS (TTM): -3.06
• Shares Outstanding: 2,119,551
• 10 Day Avg. Volume: 29,232
• 30 Day Avg. Volume: 40,481
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 6.25
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: 6.21
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Inspire Veterinary Partners, Inc. faces significant financial instability due to high leverage and negative cash flow. While the recent funding agreement is a positive step towards expansion, the stock's weak technical indicators and negative valuation metrics reflect ongoing challenges. The lack of profitability and financial resilience are key risks that weigh heavily on the overall score.

Inspire Veterinary Partners, Inc. Class A Business Overview & Revenue Model

Company Description

Inspire Veterinary Partners, Inc. Class A (IVP) is a company that operates in the veterinary services sector, focusing on providing comprehensive healthcare services for animals. The company is dedicated to enhancing the well-being of pets and livestock through its network of veterinary clinics, offering services such as medical consultations, surgical procedures, diagnostics, and preventive care.

How the Company Makes Money

Inspire Veterinary Partners, Inc. generates revenue through its network of veterinary clinics by offering a range of services to pet owners and livestock farmers. The company's primary revenue streams include fees for medical consultations, diagnostic tests, surgical procedures, and sales of veterinary products such as medications and pet food. Additionally, IVP may engage in partnerships with suppliers of veterinary products and pharmaceuticals, which can provide additional revenue through product sales and distribution agreements. Revenue is also supported by wellness plans and membership programs that encourage regular visits and preventive care, fostering customer loyalty and recurring income.

Inspire Veterinary Partners, Inc. Class A Financial Statement Overview

Summary

Inspire Veterinary Partners, Inc. demonstrates revenue growth but faces challenges with profitability and cash flow. High leverage and negative equity for most of the period highlight financial instability, raising concerns about sustainability without significant financial restructuring or operational changes.

Income Statement

Inspire Veterinary Partners, Inc. shows a consistent increase in total revenue over the past years, indicating growth potential. However, the company has consistently reported negative EBIT and net income, leading to unfavorable profit margins. The gross profit margin improved significantly in 2024, yet high operating expenses continue to weigh on profitability.

Balance Sheet

The company exhibits a high debt-to-equity ratio due to its significant total debt compared to stockholders' equity, which was negative until 2024. This indicates high financial leverage and potential risk. The equity ratio is also low, reflecting a limited buffer against liabilities.

Cash Flow

Free cash flow has been negative over the years, with a declining trend in 2024. This suggests ongoing cash flow challenges. The operating cash flow to net income ratio indicates cash flow issues, as operating cash flow is consistently negative. The company relies heavily on financing activities to support operations.

Breakdown
Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
16.68M	9.83M	2.55M	0.00
	Gross Profit
3.55M	2.55M	829.29K	0.00
	EBIT
-7.19M	-3.52M	-1.05M	-5.52K
	EBITDA
-10.84M	-2.91M	-977.46K	0.00
	Net Income Common Stockholders
-14.79M	-4.91M	-1.33M	-5.52K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
178.96K	444.25K	2.06M	21.97K
	Total Assets
21.79M	20.19M	6.33M	21.97K
	Total Debt
18.42M	23.61M	6.69M	0.00
	Net Debt
18.24M	23.17M	4.64M	-21.97K
	Total Liabilities
22.58M	25.32M	7.20M	0.00
	Stockholders Equity
-788.26K	-5.14M	-869.09K	21.97K
Cash Flow		Free Cash Flow
-4.20M	-2.84M	-2.32M	-5.52K
	Operating Cash Flow
-3.82M	-2.66M	-1.01M	-5.52K
	Investing Cash Flow
-1.87M	-14.67M	-4.02M	0.00
	Financing Cash Flow
5.63M	15.71M	7.07M	269.16K

Inspire Veterinary Partners, Inc. Class A Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.55
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IVP, the sentiment is Negative. The current price of 1.55 is above the 20-day moving average (MA) of 1.47, below the 50-day MA of 1.70, and below the 200-day MA of 24.97, indicating a bearish trend. The MACD of -0.06 indicates Negative momentum. The RSI at 40.23 is Neutral, neither overbought nor oversold. The STOCH value of 46.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IVP.

Inspire Veterinary Partners, Inc. Class A Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$6.58B	11.77	3.05%	3.99%	2.61%	-21.52%
JWEL	46 Neutral	$3.97M	―	-32.36%	―	-16.85%	-9.20%
VMAR	44 Neutral	$7.45M	―	-80.86%	―	-55.43%	55.17%
JXG	41 Neutral	$3.61M	4.25	22.23%	―	-21.60%	―
CTNT	41 Neutral	$4.28M	―	-28.60%	―	―	―
VEEE	40 Underperform	$3.94M	―	-51.70%	―	-57.08%	-45.74%
IVP	39 Underperform	$3.53M	―	-3687.07%	―	-0.50%	94.60%

Inspire Veterinary Partners, Inc. Class A Corporate Events

Inspire Veterinary Partners Secures CEO Employment Agreement

Inspire Veterinary Partners, Inc. has formalized an employment agreement with its current CEO, Kimball Carr, for an initial two-year term. The agreement outlines Mr. Carr’s responsibilities, compensation, and conditions for termination, aiming to ensure his full commitment to the company’s interests. The contract includes a base salary, performance bonuses, potential stock awards, and non-disclosure provisions, while also detailing circumstances under which either party may terminate the agreement.

Spark’s Take on IVP Stock

According to Spark, TipRanks’ AI Analyst, IVP is a Neutral.

The overall stock score reflects significant financial challenges, including high leverage and negative cash flows, which highlight potential sustainability issues. Technical analysis indicates bearish conditions, while valuation metrics remain weak due to negative earnings. However, the recent securities purchase agreement provides a glimmer of hope for strategic growth and potential recovery in the market.

To see Spark’s full report on IVP stock, click here.

Inspire Veterinary Partners Announces Securities Purchase Agreement

On March 25, 2025, Inspire Veterinary Partners announced a securities purchase agreement with an institutional investor to issue and sell shares of Class A Common Stock and warrants in a registered direct offering expected to close on March 26, 2025. This offering, priced at $1.83 per share, aims to raise approximately $2.0 million initially, with the potential for an additional $4.0 million upon full exercise of the warrants. The company has engaged D. Boral Capital LLC as the placement agent and is required to seek stockholder approval for the issuance of shares upon warrant exercise within 75 days. The move is part of Inspire’s strategy to expand its operations and acquire more veterinary hospitals, enhancing its market positioning in the pet healthcare industry.